XMicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling

Cell

Volumn 154, Issue 2, 2013, Pages 311-

  Song, Su Jung ^a   Poliseno, Laura ^a,b   Song, Min Sup ^a,c   Ala, Ugo ^a   Webster, Kaitlyn ^a   Ng, Christopher ^a   Beringer, Gary ^a   Brikbak, Nicolai J ^a   Yuan, Xin ^a   Cantley, Lewis C ^a   Richardson, Andrea L ^a   Pandolfi, Pier Paolo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CNR   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; MICRORNA 22;

ANIMAL CELL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR INVASION; XENOGRAFT;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 84880570961     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.06.026     Document Type: Article

References (74)

1. L. Adam, M. Zhong, W. Choi, W. Qi, M. Nicoloso, A. Arora, G. Calin, H. Wang, A. Siefker-Radtke, and D. McConkey miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy Clin. Cancer Res. 15 2009 5060 5072
2. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
3. A. Bendoraite, E.C. Knouf, K.S. Garg, R.K. Parkin, E.M. Kroh, K.C. O'Briant, A.P. Ventura, A.K. Godwin, B.Y. Karlan, and C.W. Drescher Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition Gynecol. Oncol. 116 2010 117 125
4. D. Betel, M. Wilson, A. Gabow, D.S. Marks, and C. Sander The microRNA.org resource: targets and expression Nucleic Acids Res. 36 Database issue 2008 D149 D153
5. B. Bierie, and H.L. Moses Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer Nat. Rev. Cancer 6 2006 506 520
6. K. Breving, and A. Esquela-Kerscher The complexities of microRNA regulation: mirandering around the rules Int. J. Biochem. Cell Biol. 42 2010 1316 1329
7. F.M. Buffa, C. Camps, L. Winchester, C.E. Snell, H.E. Gee, H. Sheldon, M. Taylor, A.L. Harris, and J. Ragoussis microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer Cancer Res. 71 2011 5635 5645
8. G.A. Calin, M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, and M. Fabbri A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N. Engl. J. Med. 353 2005 1793 1801
9. C.L. Chaffer, and R.A. Weinberg A perspective on cancer cell metastasis Science 331 2011 1559 1564
10. V. Davalos, C. Moutinho, A. Villanueva, R. Boque, P. Silva, F. Carneiro, and M. Esteller Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis Oncogene 31 2012 2062 2074
11. M.S. Ebert, J.R. Neilson, and P.A. Sharp MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nat. Methods 4 2007 721 726
12. E. Enerly, I. Steinfeld, K. Kleivi, S.K. Leivonen, M.R. Aure, H.G. Russnes, J.A. Rønneberg, H. Johnsen, R. Navon, and E. Rødland miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors PLoS ONE 6 2011 e16915
13. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
14. I.J. Fidler The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat. Rev. Cancer 3 2003 453 458
15. M.E. Figueroa, O. Abdel-Wahab, C. Lu, P.S. Ward, J. Patel, A. Shih, Y. Li, N. Bhagwat, A. Vasanthakumar, and H.F. Fernandez Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
16. P.A. Gregory, A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, and G.J. Goodall The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat. Cell Biol. 10 2008 593 601
17. S. Griffiths-Jones, R.J. Grocock, S. van Dongen, A. Bateman, and A.J. Enright miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res. 34 Database issue 2006 D140 D144
18. G.P. Gupta, and J. Massagué Cancer metastasis: building a framework Cell 127 2006 679 695
19. C.T. Guy, R.D. Cardiff, and W.J. Muller Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease Mol. Cell. Biol. 12 1992 954 961
20. C.T. Guy, M.A. Webster, M. Schaller, T.J. Parsons, R.D. Cardiff, and W.J. Muller Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc. Natl. Acad. Sci. USA 89 1992 10578 10582
21. M.C. Haffner, A. Chaux, A.K. Meeker, D.M. Esopi, J. Gerber, L.G. Pellakuru, A. Toubaji, P. Argani, C. Iacobuzio-Donahue, and W.G. Nelson Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers Oncotarget 2 2011 627 637
22. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, and S.M. Hammond A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833
23. I. Ibarra, Y. Erlich, S.K. Muthuswamy, R. Sachidanandam, and G.J. Hannon A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells Genes Dev. 21 2007 3238 3243
24. D. Iliopoulos, M. Lindahl-Allen, C. Polytarchou, H.A. Hirsch, P.N. Tsichlis, and K. Struhl Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells Mol. Cell 39 2010 761 772
25. K. Ito, R. Bernardi, and P.P. Pandolfi A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell Curr. Opin. Genet. Dev. 19 2009 51 59
26. S. Ito, A.C. D'Alessio, O.V. Taranova, K. Hong, L.C. Sowers, and Y. Zhang Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification Nature 466 2010 1129 1133
27. A.J. Jackson-Fisher, G. Bellinger, R. Ramabhadran, J.K. Morris, K.F. Lee, and D.F. Stern ErbB2 is required for ductal morphogenesis of the mammary gland Proc. Natl. Acad. Sci. USA 101 2004 17138 17143
28. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
29. M. Ko, Y. Huang, A.M. Jankowska, U.J. Pape, M. Tahiliani, H.S. Bandukwala, J. An, E.D. Lamperti, K.P. Koh, and R. Ganetzky Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 Nature 468 2010 839 843
30. S.M. Langemeijer, R.P. Kuiper, M. Berends, R. Knops, M.G. Aslanyan, M. Massop, E. Stevens-Linders, P. van Hoogen, A.G. van Kessel, and R.A. Raymakers Acquired mutations in TET2 are common in myelodysplastic syndromes Nat. Genet. 41 2009 838 842
31. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
32. A. Li, N. Omura, S.M. Hong, A. Vincent, K. Walter, M. Griffith, M. Borges, and M. Goggins Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels Cancer Res. 70 2010 5226 5237
33. B. Ling, G.X. Wang, G. Long, J.H. Qiu, and Z.L. Hu Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3 J. Cancer Res. Clin. Oncol. 138 2012 1355 1361
34. A. Lujambio, S. Ropero, E. Ballestar, M.F. Fraga, C. Cerrato, F. Setién, S. Casado, A. Suarez-Gauthier, M. Sanchez-Cespedes, and A. Git Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res. 67 2007 1424 1429
35. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
36. I. Malanchi, A. Santamaria-Martínez, E. Susanto, H. Peng, H.A. Lehr, J.F. Delaloye, and J. Huelsken Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 2012 85 89
37. J.B. McCarthy, M.L. Basara, S.L. Palm, D.F. Sas, and L.T. Furcht The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells Cancer Metastasis Rev. 4 1985 125 152
38. D. Melisi, S. Ishiyama, G.M. Sclabas, J.B. Fleming, Q. Xia, G. Tortora, J.L. Abbruzzese, and P.J. Chiao LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis Mol. Cancer Ther. 7 2008 829 840
39. D.J. Mulholland, N. Kobayashi, M. Ruscetti, A. Zhi, L.M. Tran, J. Huang, M. Gleave, and H. Wu Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells Cancer Res. 72 2012 1878 1889
40. C.E. Nestor, R. Ottaviano, J. Reddington, D. Sproul, D. Reinhardt, D. Dunican, E. Katz, J.M. Dixon, D.J. Harrison, and R.R. Meehan Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes Genome Res. 22 2012 467 477
41. R. Neves, C. Scheel, S. Weinhold, E. Honisch, K.M. Iwaniuk, H.I. Trompeter, D. Niederacher, P. Wernet, S. Santourlidis, and M. Uhrberg Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells BMC Res Notes 3 2010 219
42. P. Olson, J. Lu, H. Zhang, A. Shai, M.G. Chun, Y. Wang, S.K. Libutti, E.K. Nakakura, T.R. Golub, and D. Hanahan MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer Genes Dev. 23 2009 2152 2165
43. D.P. Pandey, and D. Picard miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA Mol. Cell. Biol. 29 2009 3783 3790
44. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev. 22 2008 894 907
45. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7 2007 415 428
46. L. Poliseno, L. Salmena, L. Riccardi, A. Fornari, M.S. Song, R.M. Hobbs, P. Sportoletti, S. Varmeh, A. Egia, and G. Fedele Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation Sci. Signal. 3 2010 ra29
47. E.S. Radisky, and D.C. Radisky Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer J. Mammary Gland Biol. Neoplasia 15 2010 201 212
48. Y. Saito, G. Liang, G. Egger, J.M. Friedman, J.C. Chuang, G.A. Coetzee, and P.A. Jones Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443
49. A.H. Shih, O. Abdel-Wahab, J.P. Patel, and R.L. Levine The role of mutations in epigenetic regulators in myeloid malignancies Nat. Rev. Cancer 12 2012 599 612
50. Y. Shimono, M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu, S.P. Panula, and E. Chiao Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 2009 592 603
51. B.Y. Shorning, D. Griffiths, and A.R. Clarke Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder PLoS ONE 6 2011 e16209
52. S.J. Song, K. Ito, U. Ala, L. Kats, K. Webster, S.M. Sun, M. Jongen-Lavrencic, K. Manova-Todorova, J. Teruya-Feldstein, and D.E. Avigan The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation Cell Stem Cell 13 2013 87 101
53. C.X. Song, K.E. Szulwach, Y. Fu, Q. Dai, C. Yi, X. Li, Y. Li, C.H. Chen, W. Zhang, and X. Jian Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine Nat. Biotechnol. 29 2011 68 72
54. M. Tahiliani, K.P. Koh, Y. Shen, W.A. Pastor, H. Bandukwala, Y. Brudno, S. Agarwal, L.M. Iyer, D.R. Liu, L. Aravind, and A. Rao Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 2009 930 935
55. M. Toyota, H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, Y. Shinomura, and T. Tokino Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer Cancer Res. 68 2008 4123 4132
56. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 8 2008 755 768
57. L. Vrba, T.J. Jensen, J.C. Garbe, R.L. Heimark, A.E. Cress, S. Dickinson, M.R. Stampfer, and B.W. Futscher Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells PLoS ONE 5 2010 e8697
58. M. Vuoristo, P. Vihinen, T. Vlaykova, C. Nylund, J. Heino, and S. Pyrhönen Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma Melanoma Res. 17 2007 215 223
59. T. Wang, L. Zhang, C. Shi, H. Sun, J. Wang, R. Li, Z. Zou, X. Ran, and Y. Su TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells Int. J. Biochem. Cell Biol. 44 2012 366 376
60. N.P. Withana, G. Blum, M. Sameni, C. Slaney, A. Anbalagan, M.B. Olive, B.N. Bidwell, L. Edgington, L. Wang, and K. Moin Cathepsin B inhibition limits bone metastasis in breast cancer Cancer Res. 72 2012 1199 1209
61. S.C. Wu, and Y. Zhang Active DNA demethylation: many roads lead to Rome Nat. Rev. Mol. Cell Biol. 11 2010 607 620
62. J. Xiong, D. Yu, N. Wei, H. Fu, T. Cai, Y. Huang, C. Wu, X. Zheng, Q. Du, D. Lin, and Z. Liang An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples FEBS J. 277 2010 1684 1694
63. H. Yang, Y. Liu, F. Bai, J.Y. Zhang, S.H. Ma, J. Liu, Z.D. Xu, H.G. Zhu, Z.Q. Ling, and D. Ye Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation Oncogene 32 2013 663 669
64. N. Yoshimoto, T. Toyama, S. Takahashi, H. Sugiura, Y. Endo, M. Iwasa, Y. Fujii, and H. Yamashita Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer Breast Cancer Res. Treat. 130 2011 331 339
65. T. Davis, and R. Vaisvila High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue J. Vis. Exp. 48 2011 e2661
66. J. Debnath, S.K. Muthuswamy, and J.S. Brugge Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 2003 256 268
67. G. Ficz, M.R. Branco, S. Seisenberger, F. Santos, F. Krueger, T.A. Hore, C.J. Marques, S. Andrews, and W. Reik Dynamic regulation of 5- hydroxymethylcytosine in mouse ES cells and during differentiation Nature 473 2011 398 402
68. R. Firestein, G. Blander, S. Michan, P. Oberdoerffer, S. Ogino, J. Campbell, A. Bhimavarapu, S. Luikenhuis, R. de Cabo, and C. Fuchs The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth PLoS ONE 3 2008 e2020
69. C. Gewinner, Z.C. Wang, A. Richardson, J. Teruya-Feldstein, D. Etemadmoghadam, D. Bowtell, J. Barretina, W.M. Lin, L. Rameh, and L. Salmena Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling Cancer Cell 16 2009 115 125
70. W.E. Hardman, M.P. Moyer, and I.L. Cameron Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects Br. J. Cancer 81 1999 440 448
71. T. Kasukabe, J. Okabe-Kado, N. Kato, T. Sassa, and Y. Honma Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation- inducing agent, on human breast carcinoma MCF-7 cells and xenografts Breast Cancer Res. 7 2005 R1097 R1110
72. M. Shackleton, F. Vaillant, K.J. Simpson, J. Stingl, G.K. Smyth, M.L. Asselin-Labat, L. Wu, G.J. Lindeman, and J.E. Visvader Generation of a functional mammary gland from a single stem cell Nature 439 2006 84 88
73. J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H.I. Li, and C.J. Eaves Purification and unique properties of mammary epithelial stem cells Nature 439 2006 993 997
74. J. Zhou, H. Zhang, P. Gu, J. Bai, J.B. Margolick, and Y. Zhang NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells Breast Cancer Res. Treat. 111 2008 419 427